Dr. Campbell current MD and CEO of Partrys was previously the COO and CFO of ChemGenex Pharmaceuticals Limited (ASX:CXS), with responsibilities ranging from business development through to IP management and including finance and governance . As a member of the ChemGenex executive team he helped transform a research-based company with a market capitalisation of approximately A$10M to a company with completed clinical trials and regulatory dossiers submitted to the FDA and EMA. In 2011, ChemGenex was sold to Cephalon for A$230M.
Currently we are at MC of Circa $8. He must have seen something in PAB product and must be confident enough to turn this around.
cheers
J
- Forums
- ASX - By Stock
- Ann: Manufacturing Update - Clinical Trial Remains on Hold
Dr. Campbell current MD and CEO of Partrys was previously the...
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.001(16.7%) |
Mkt cap ! $14.40M |
Open | High | Low | Value | Volume |
0.5¢ | 0.7¢ | 0.5¢ | $7.228K | 1.211M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 804100 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 984649 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 804100 | 0.006 |
19 | 10094557 | 0.005 |
10 | 5864000 | 0.004 |
5 | 5899016 | 0.003 |
1 | 2520000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 984649 | 3 |
0.008 | 2561393 | 6 |
0.009 | 80000 | 1 |
0.010 | 1396000 | 6 |
0.012 | 292407 | 2 |
Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |